Patrys Competitors and Similar CompaniesClear all
Patrys's competitors and similar companies include Stemline Therapeutics, Exelixis, TRACON Pharmaceuticals and Carna Biosciences.
 Patrys Patrys is a drug development company that commercializes antibody technologies for the treatment of cancer. |  Stemline Therapeutics Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells. |  TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. |  Carna Biosciences Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. | ||
Founding Date | Founding Date 2007 | Founding Date 2003 | Founding Date 1994 | Founding Date 2006 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South Melbourne, AU HQ | Locations New York, US HQ | Locations Alameda, US HQ | Locations San Diego, US HQ | Locations Kobe, JP HQ Natick, US |
Employees | Employees N/A | Employees 100 | Employees 1,14712% decrease | Employees 268% increase | Employees 65 |
Valuation ($) | Valuation ($) 5.4 m | Valuation ($) 621.2 m | Valuation ($) 8.2 b | Valuation ($) 279.4 k | Valuation ($) 38.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $807k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) ¥579.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $4.9m (FY, 2019) | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A | Cost of goods ¥190.9m (FY, 2025) |
Gross profit | Gross profit $807k (FY, 2025) | Gross profit N/A | Gross profit $2.2b (FY, 2025) | Gross profit N/A | Gross profit ¥388.1m (FY, 2025) |
Net income | Net income ($3m) (FY, 2025) | Net income ($76.8m) (FY, 2019) | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) | Net income (¥2.2b) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Stemline Therapeutics
HQ
New York, US
Employees
100
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyTRACON Pharmaceuticals
HQ
San Diego, US
Employees
26↑ 8% increase
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View companyCarna Biosciences
HQ
Kobe, JP
Employees
65
Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services.
View company